GPX4 and neoplasm: Following FABP5 inhibition via nanocarriers, C11‐BODIPY fluorescence assays revealed a significant increase in lipid peroxidation and a corresponding decrease in GPX4 expression in tumor cells, indicating that FABP5 inhibition enhances RFA‐induced ferroptosis (Figure S8A, Supporting Information).